Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 091648

Expand all

TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; TELMISARTAN)
12.5MG;40MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; TELMISARTAN
Proprietary Name: TELMISARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;40MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A091648
Product Number: 001
Approval Date: Feb 25, 2014
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; TELMISARTAN)
12.5MG;80MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; TELMISARTAN
Proprietary Name: TELMISARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A091648
Product Number: 002
Approval Date: Feb 25, 2014
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; TELMISARTAN)
25MG;80MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; TELMISARTAN
Proprietary Name: TELMISARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A091648
Product Number: 003
Approval Date: Feb 25, 2014
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information